Granulocyte-Colony Stimulating Factor Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Tablet, Capsule, Others); Application (Oncology, Blood Disorder, Acute and Chronic Diseases, Growth Hormone Diseases, Others) and Geography

Report Code: TIPRE00004050 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET OVERVIEW

G-CSF is a glycoprotein that stimulates the production of stem cells and granulocytes in the bone marrow and then releases them into the bloodstream. G-CSF is produced by different of tissues, and its pharmacological analogues include filgrastim and lenograstim. G-CSF also stimulates survival, proliferation, differentiation, and function of mature & neutrophil precursors. G-CSF has several applications in haematology and oncology; for example, a recombinant form of G-CSF is used with some cancer patients to reduce mortality and speed recovery from neutropenia after chemotherapy, allowing for higher-intensity treatment regimens.

MARKET SCOPE

The "Global Granulocyte-Colony Stimulating Factor Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the granulocyte-colony stimulating factor market with detailed market segmentation by drug product and application. The report provides key statistics on the market status of the leading granulocyte-colony stimulating factor market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •   Based on product the market is segmented as, tablet, capsule and others.
  •   On the basis of application the market is classified oncology, blood disorder, acute and chronic diseases and growth hormone diseases and others.

MARKET DYNAMICS
Drivers:

  •   Growing prevalences of cancers and other chronic disorders.
  •   Advancements and developments in genomics technology and healthcare are expected to spur the market growth during the forecast period.
  •   Ongoing R&D activities to develop therapies for management of maliganancies and their complications.

Restraints:

  •   However, high cost the treatment and possibility of other side effects may restrain market growth during the forecast period.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The granulocyte-colony stimulating factor market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the granulocyte-colony stimulating factor market in these regions.

IMPACT OF COVID-19 ON GRANULOCYTE-COLONY STIMULATING FACTOR MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. Due to restrictions and lockdowns imposed there is a big shift in the cancer treatment as people cannot go out for their treatments which is affecting the market growth of granulocyte-colony stimulating factor agents. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

MARKET PLAYERS

The report covers key developments in the granulocyte-colony stimulating factor market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from granulocyte-colony stimulating factor market are anticipated to lucrative growth opportunities in the future with the rising demand for granulocyte-colony stimulating factor in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the granulocyte-colony stimulating factor market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •   Intas Pharmaceuticals Ltd
  •   Sandoz Inc
  •   Amgen Inc
  •   Teva Pharmaceutical Industries Ltd
  •   STADA Arzneimittel AG
  •   Novartis AG
  •   Biocad
  •   Biocon
  •   Pfizer Inc
  •   Dr. Reddy's Laboratories Ltd
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Granulocyte-Colony Stimulating Factor Market - By Product
1.3.2 Granulocyte-Colony Stimulating Factor Market - By Application
1.3.3 Granulocyte-Colony Stimulating Factor Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. GRANULOCYTE-COLONY STIMULATING FACTOR MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS

5. GRANULOCYTE-COLONY STIMULATING FACTOR MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. GRANULOCYTE-COLONY STIMULATING FACTOR MARKET - GLOBAL MARKET ANALYSIS
6.1. GRANULOCYTE-COLONY STIMULATING FACTOR - GLOBAL MARKET OVERVIEW
6.2. GRANULOCYTE-COLONY STIMULATING FACTOR - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE

7. GRANULOCYTE-COLONY STIMULATING FACTOR MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. TABLET
7.3.1. Overview
7.3.2. Tablet Market Forecast and Analysis
7.4. CAPSULE
7.4.1. Overview
7.4.2. Capsule Market Forecast and Analysis
7.5. OTHERS
7.5.1. Overview
7.5.2. Others Market Forecast and Analysis
8. GRANULOCYTE-COLONY STIMULATING FACTOR MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. ONCOLOGY
8.3.1. Overview
8.3.2. Oncology Market Forecast and Analysis
8.4. BLOOD DISORDER
8.4.1. Overview
8.4.2. Blood Disorder Market Forecast and Analysis
8.5. ACUTE AND CHRONIC DISEASES
8.5.1. Overview
8.5.2. Acute and Chronic Diseases Market Forecast and Analysis
8.6. GROWTH HORMONE DISEASES
8.6.1. Overview
8.6.2. Growth Hormone Diseases Market Forecast and Analysis
8.7. OTHERS
8.7.1. Overview
8.7.2. Others Market Forecast and Analysis

9. GRANULOCYTE-COLONY STIMULATING FACTOR MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Granulocyte-Colony Stimulating Factor Market Overview
9.1.2 North America Granulocyte-Colony Stimulating Factor Market Forecasts and Analysis
9.1.3 North America Granulocyte-Colony Stimulating Factor Market Forecasts and Analysis - By Product
9.1.4 North America Granulocyte-Colony Stimulating Factor Market Forecasts and Analysis - By Application
9.1.5 North America Granulocyte-Colony Stimulating Factor Market Forecasts and Analysis - By Countries
9.1.5.1 United States Granulocyte-Colony Stimulating Factor Market
9.1.5.1.1 United States Granulocyte-Colony Stimulating Factor Market by Product
9.1.5.1.2 United States Granulocyte-Colony Stimulating Factor Market by Application
9.1.5.2 Canada Granulocyte-Colony Stimulating Factor Market
9.1.5.2.1 Canada Granulocyte-Colony Stimulating Factor Market by Product
9.1.5.2.2 Canada Granulocyte-Colony Stimulating Factor Market by Application
9.1.5.3 Mexico Granulocyte-Colony Stimulating Factor Market
9.1.5.3.1 Mexico Granulocyte-Colony Stimulating Factor Market by Product
9.1.5.3.2 Mexico Granulocyte-Colony Stimulating Factor Market by Application
9.2. EUROPE
9.2.1 Europe Granulocyte-Colony Stimulating Factor Market Overview
9.2.2 Europe Granulocyte-Colony Stimulating Factor Market Forecasts and Analysis
9.2.3 Europe Granulocyte-Colony Stimulating Factor Market Forecasts and Analysis - By Product
9.2.4 Europe Granulocyte-Colony Stimulating Factor Market Forecasts and Analysis - By Application
9.2.5 Europe Granulocyte-Colony Stimulating Factor Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Granulocyte-Colony Stimulating Factor Market
9.2.5.1.1 Germany Granulocyte-Colony Stimulating Factor Market by Product
9.2.5.1.2 Germany Granulocyte-Colony Stimulating Factor Market by Application
9.2.5.2 France Granulocyte-Colony Stimulating Factor Market
9.2.5.2.1 France Granulocyte-Colony Stimulating Factor Market by Product
9.2.5.2.2 France Granulocyte-Colony Stimulating Factor Market by Application
9.2.5.3 Italy Granulocyte-Colony Stimulating Factor Market
9.2.5.3.1 Italy Granulocyte-Colony Stimulating Factor Market by Product
9.2.5.3.2 Italy Granulocyte-Colony Stimulating Factor Market by Application
9.2.5.4 Spain Granulocyte-Colony Stimulating Factor Market
9.2.5.4.1 Spain Granulocyte-Colony Stimulating Factor Market by Product
9.2.5.4.2 Spain Granulocyte-Colony Stimulating Factor Market by Application
9.2.5.5 United Kingdom Granulocyte-Colony Stimulating Factor Market
9.2.5.5.1 United Kingdom Granulocyte-Colony Stimulating Factor Market by Product
9.2.5.5.2 United Kingdom Granulocyte-Colony Stimulating Factor Market by Application
9.2.5.6 Rest of Europe Granulocyte-Colony Stimulating Factor Market
9.2.5.6.1 Rest of Europe Granulocyte-Colony Stimulating Factor Market by Product
9.2.5.6.2 Rest of Europe Granulocyte-Colony Stimulating Factor Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Granulocyte-Colony Stimulating Factor Market Overview
9.3.2 Asia-Pacific Granulocyte-Colony Stimulating Factor Market Forecasts and Analysis
9.3.3 Asia-Pacific Granulocyte-Colony Stimulating Factor Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Granulocyte-Colony Stimulating Factor Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Granulocyte-Colony Stimulating Factor Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Granulocyte-Colony Stimulating Factor Market
9.3.5.1.1 Australia Granulocyte-Colony Stimulating Factor Market by Product
9.3.5.1.2 Australia Granulocyte-Colony Stimulating Factor Market by Application
9.3.5.2 China Granulocyte-Colony Stimulating Factor Market
9.3.5.2.1 China Granulocyte-Colony Stimulating Factor Market by Product
9.3.5.2.2 China Granulocyte-Colony Stimulating Factor Market by Application
9.3.5.3 India Granulocyte-Colony Stimulating Factor Market
9.3.5.3.1 India Granulocyte-Colony Stimulating Factor Market by Product
9.3.5.3.2 India Granulocyte-Colony Stimulating Factor Market by Application
9.3.5.4 Japan Granulocyte-Colony Stimulating Factor Market
9.3.5.4.1 Japan Granulocyte-Colony Stimulating Factor Market by Product
9.3.5.4.2 Japan Granulocyte-Colony Stimulating Factor Market by Application
9.3.5.5 South Korea Granulocyte-Colony Stimulating Factor Market
9.3.5.5.1 South Korea Granulocyte-Colony Stimulating Factor Market by Product
9.3.5.5.2 South Korea Granulocyte-Colony Stimulating Factor Market by Application
9.3.5.6 Rest of Asia-Pacific Granulocyte-Colony Stimulating Factor Market
9.3.5.6.1 Rest of Asia-Pacific Granulocyte-Colony Stimulating Factor Market by Product
9.3.5.6.2 Rest of Asia-Pacific Granulocyte-Colony Stimulating Factor Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Granulocyte-Colony Stimulating Factor Market Overview
9.4.2 Middle East and Africa Granulocyte-Colony Stimulating Factor Market Forecasts and Analysis
9.4.3 Middle East and Africa Granulocyte-Colony Stimulating Factor Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Granulocyte-Colony Stimulating Factor Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Granulocyte-Colony Stimulating Factor Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Granulocyte-Colony Stimulating Factor Market
9.4.5.1.1 South Africa Granulocyte-Colony Stimulating Factor Market by Product
9.4.5.1.2 South Africa Granulocyte-Colony Stimulating Factor Market by Application
9.4.5.2 Saudi Arabia Granulocyte-Colony Stimulating Factor Market
9.4.5.2.1 Saudi Arabia Granulocyte-Colony Stimulating Factor Market by Product
9.4.5.2.2 Saudi Arabia Granulocyte-Colony Stimulating Factor Market by Application
9.4.5.3 U.A.E Granulocyte-Colony Stimulating Factor Market
9.4.5.3.1 U.A.E Granulocyte-Colony Stimulating Factor Market by Product
9.4.5.3.2 U.A.E Granulocyte-Colony Stimulating Factor Market by Application
9.4.5.4 Rest of Middle East and Africa Granulocyte-Colony Stimulating Factor Market
9.4.5.4.1 Rest of Middle East and Africa Granulocyte-Colony Stimulating Factor Market by Product
9.4.5.4.2 Rest of Middle East and Africa Granulocyte-Colony Stimulating Factor Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Granulocyte-Colony Stimulating Factor Market Overview
9.5.2 South and Central America Granulocyte-Colony Stimulating Factor Market Forecasts and Analysis
9.5.3 South and Central America Granulocyte-Colony Stimulating Factor Market Forecasts and Analysis - By Product
9.5.4 South and Central America Granulocyte-Colony Stimulating Factor Market Forecasts and Analysis - By Application
9.5.5 South and Central America Granulocyte-Colony Stimulating Factor Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Granulocyte-Colony Stimulating Factor Market
9.5.5.1.1 Brazil Granulocyte-Colony Stimulating Factor Market by Product
9.5.5.1.2 Brazil Granulocyte-Colony Stimulating Factor Market by Application
9.5.5.2 Argentina Granulocyte-Colony Stimulating Factor Market
9.5.5.2.1 Argentina Granulocyte-Colony Stimulating Factor Market by Product
9.5.5.2.2 Argentina Granulocyte-Colony Stimulating Factor Market by Application
9.5.5.3 Rest of South and Central America Granulocyte-Colony Stimulating Factor Market
9.5.5.3.1 Rest of South and Central America Granulocyte-Colony Stimulating Factor Market by Product
9.5.5.3.2 Rest of South and Central America Granulocyte-Colony Stimulating Factor Market by Application

10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. GRANULOCYTE-COLONY STIMULATING FACTOR MARKET, KEY COMPANY PROFILES
11.1. INTAS PHARMACEUTICALS LTD
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. SANDOZ INC
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. AMGEN INC
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. TEVA PHARMACEUTICAL INDUSTRIES LTD
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. STADA ARZNEIMITTEL AG
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. NOVARTIS AG
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. BIOCAD
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. BIOCON
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. PFIZER INC
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. DR. REDDY'S LABORATORIES LTD
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
"
The List of Companies

1. Intas Pharmaceuticals Ltd
2. Sandoz Inc
3. Amgen Inc
4. Teva Pharmaceutical Industries Ltd
5. STADA Arzneimittel AG
6. Novartis AG
7. Biocad
8. Biocon
9. Pfizer Inc
10. Dr. Reddy's Laboratories Ltd
TIPRE00004050
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking